QIASEQ

QIAGEN GmbH

Application Filed: 2016-10-21

Trademark Application Details

Status

700

Live/Registered

REGISTERED

Research	OneLook Acronym Finder
Serial Number	79201919
Registration Number	5288349
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Randolph E. Digges, III
Attorney Docket Number	GIL-42262
Law Office Assigned	M30
Employee Name	LAM, HAI-LY HUYNH

Timeline

2016-10-21	Application Filed
2017-07-04	Published for Opposition
2017-09-19	Location: PUBLICATION AND ISSUE SECTION
2017-09-19	Status: Live/Registered
2017-09-19	Trademark Registered
2019-05-16	Transaction Date

Trademark Applicants & Owners

Owner:	QIAGEN GmbH
Entity Statement	GmbH
Address	Qiagen Str. 1 40724 Hilden DE
Legal Entity Type
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Randolph E. Digges, III
Rankin, Hill & Clark LLP
P.O. BOX 1150
BONITA SPRINGS FL 34133-1150

Good, Services, and Codes

International Codes:	1
U.S. Codes:	001,005,006,010,026,046
International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	9
U.S. Codes:	021,023,026,036,038

Type Code	Type
GS0011	Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes; non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use, namely, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing all for scientific or medical research use; kits comprising chemicals for sample preparation, modification and manipulation of cells for scientific purposes, other than for medical or veterinary use; kits comprising chemicals for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material all for scientific purposes, other than for medical or veterinary use; kits comprising in particular chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing for scientific purposes, other than for medical or veterinary use

Type Code

Type

GS0011

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes; non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use, namely, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing all for scientific or medical research use; kits comprising chemicals for sample preparation, modification and manipulation of cells for scientific purposes, other than for medical or veterinary use; kits comprising chemicals for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material all for scientific purposes, other than for medical or veterinary use; kits comprising in particular chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing for scientific purposes, other than for medical or veterinary use

Trademark Filing History

Description	Date	Event Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB	2017-02-23	1 REPR M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2017-02-24	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2017-02-24	3 DOCK D:Assigned to Examiner
APPLICATION FILING RECEIPT MAILED	2017-02-28	4 MAFR O:Outgoing Correspondence
NON-FINAL ACTION WRITTEN	2017-03-02	5 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	2017-03-03	6 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU	2017-03-04	7 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	2017-03-04	8 RFCS P:
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2017-03-14	9 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2017-03-14	10 ARAA I:Incoming Correspondence
REFUSAL PROCESSED BY IB	2017-03-25	11 RFNT P:
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2017-04-06	12 TROA I:Incoming Correspondence
ASSIGNED TO LIE	2017-04-21	13 ALIE A:Allowance for Publication
ASSIGNED TO LIE	2017-05-13	14 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE	2017-05-13	15 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2017-05-13	16 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2017-05-23	17 CNSA O:Outgoing Correspondence
LAW OFFICE PUBLICATION REVIEW COMPLETED	2017-05-27	18 PREV O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2017-06-14	19 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2017-07-04	20 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2017-07-04	21 NPUB E:E-Mail
REGISTERED-PRINCIPAL REGISTER	2017-09-19	22 R.PR A:Allowance for Publication
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	2017-12-19	23 FICR P:
FINAL DISPOSITION PROCESSED	2018-01-12	24 FIMP P:
FINAL DISPOSITION NOTICE SENT TO IB	2018-01-12	25 FICS P:
FINAL DECISION TRANSACTION PROCESSED BY IB	2018-02-10	26 FINO P:
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2019-05-14	27 TCCA I:Incoming Correspondence
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED	2022-09-19	28 REM3 E:E-Mail
TEAS SECTION 71 & 15 RECEIVED	2023-08-30	29 ES75 I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2024-04-23	30 APRE A:Allowance for Publication
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.	2024-04-24	31 C75A O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED	2024-04-24	32 NA75 E:E-Mail

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.